MA (EU) number
(Invented) 
name
Strength
Pharmaceutical 
Form
Route of 
Administration
Immediate 
Packaging
Content 
(concentration)
Pack size
EU/1/17/1187/001 Trumenba
EU/1/17/1187/002 Trumenba
EU/1/17/1187/003 Trumenba
--1
--1
--1
Suspension for 
injection
Intramuscular 
use
pre-filled 
syringe (glass)
0.5 ml
Suspension for 
injection
Intramuscular 
use
pre-filled 
syringe (glass)
0.5 ml
Suspension for 
injection
Intramuscular 
use
pre-filled 
syringe (glass)
0.5 ml
EU/1/17/1187/004 Trumenba
--1
Suspension for 
injection
Intramuscular 
use
pre-filled 
syringe (glass)
0.5 ml
EU/1/17/1187/005 Trumenba
--1
Suspension for 
injection
Intramuscular 
use
pre-filled 
syringe (glass)
0.5 ml
EU/1/17/1187/006 Trumenba
--1
Suspension for 
injection
Intramuscular 
use
pre-filled 
syringe (glass)
0.5 ml
--1
1 dose (0.5 ml) contains:
Neisseria meningitidis serogroup B fHbp subfamily A 1,2,3                                            60 micrograms
Neisseria meningitidis serogroup B fHbp subfamily B 1,2,3                                            60 micrograms
1 Recombinant lipidated fHbp (factor H binding protein)
2 Produced in Escherichia coli cells by recombinant DNA technology
3 Adsorbed on aluminium phosphate (0.25 milligram aluminium per dose)
1 pre-filled syringe 
with needle
1 pre-filled syringe 
without needle
5 pre-filled 
syringes with 
needles
5 pre-filled 
syringes without 
needles
10 pre-filled 
syringes with 
needles
10 pre-filled 
syringes without 
needles
1/1
  
